The Trump administration is reportedly poised to link Tylenol use during pregnancy to autism risk, contradicting medical consensus. This announcement, teased by President Trump, also involves exploring leucovorin as a potential autism treatment. While some studies show leucovorin's potential benefits, the link between Tylenol and autism lacks widespread scientific support. The claims are controversial, given the established safety of Tylenol for pregnant women and the lack of definitive autism causes.

Prepared by Olivia Bennett and reviewed by editorial team.